Howe & Rusling’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32K | Hold |
386
| – | – | ﹤0.01% | 369 |
|
|
2025
Q1 | $31.3K | Sell |
386
-133
| -26% | -$10.8K | ﹤0.01% | 340 |
|
|
2024
Q4 | $46.7K | Buy |
519
+19
| +4% | +$1.71K | ﹤0.01% | 318 |
|
|
2024
Q3 | $49.4K | Buy |
+500
| New | +$49.4K | ﹤0.01% | 301 |
|
|
2022
Q2 | – | Sell |
-18
| Closed | -$2K | – | 1170 |
|
|
2022
Q1 | $2K | Buy |
+18
| New | +$2K | ﹤0.01% | 896 |
|
|
2020
Q3 | – | Sell |
-65
| Closed | -$7K | – | 880 |
|
|
2020
Q2 | $7K | Buy |
65
+27
| +71% | +$2.91K | ﹤0.01% | 495 |
|
|
2020
Q1 | $3K | Buy |
+38
| New | +$3K | ﹤0.01% | 598 |
|
|
2019
Q1 | – | Sell |
-400
| Closed | -$29K | – | 899 |
|
|
2018
Q4 | $29K | Buy |
400
+100
| +33% | +$7.25K | 0.01% | 305 |
|
|
2018
Q3 | $29K | Buy |
+300
| New | +$29K | ﹤0.01% | 341 |
|